What is the most appropriate intervention for a patient who develops atrial fibrillation post-cardiac surgery?

Choice A rationale Anticoagulation is a critical component in the long-term management of atrial fibrillation to prevent systemic thromboembolism and stroke. However, in the immediate post-cardiac surgery period, the primary physiological concern is hemodynamic stability and the prevention of rapid ventricular response. While anticoagulants may be started later, they do not address the acute electrical instability or the high heart rate that can compromise cardiac output immediately following a surgical procedure involving the heart tissues or vessels. Choice B rationale Advising a patient to avoid exertion is a general supportive measure but does not constitute a clinical intervention for an arrhythmia. Atrial fibrillation involves disorganized atrial electrical activity that leads to an irregular and often rapid pulse. Simply resting will not convert the rhythm or control the rate effectively. Medical management is required to prevent complications such as heart failure or myocardial ischemia, which can occur if the heart rate remains persistently high during the postoperative recovery phase. Choice C rationale Beta blockers are the first-line treatment for rate control in postoperative atrial fibrillation. By blocking sympathetic stimulation to the heart, these medications slow conduction through the atrioventricular node. This reduces the ventricular rate, allowing for better diastolic filling and improved stroke volume. Controlling the rate is often prioritized over rhythm conversion because many postoperative cases of atrial fibrillation are transient and resolve spontaneously once the inflammatory response to surgery diminishes and electrolyte balance is fully restored. Choice D rationale Synchronized cardioversion is a procedure used to shock the heart back into a normal sinus rhythm. While effective, it is generally reserved for patients who are hemodynamically unstable, such as those with severe hypotension, pulmonary edema, or active chest pain resulting from the arrhythmia. For a stable postoperative patient, pharmacological rate control is typically attempted first. Cardioversion carries risks, including the dislodgement of existing clots, and is not the most appropriate initial intervention for a stable patient.